Cargando…

Reactivity and binding mode of disulfiram, its metabolites, and derivatives in SARS-CoV-2 PL(pro): insights from computational chemistry studies

The papain-like protease (PL(pro)) from SARS-CoV-2 is an important target for the development of antivirals against COVID-19. The safe drug disulfiram (DSF) presents antiviral activity inhibiting PL(pro) in vitro, and it is under clinical trial studies, indicating to be a promising anti-COVID-19 dru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nogara, Pablo Andrei, Omage, Folorunsho Bright, Bolzan, Gustavo Roni, Delgado, Cássia Pereira, Orian, Laura, Rocha, João Batista Teixeira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554863/ https://www.ncbi.nlm.nih.gov/pubmed/36222962 http://dx.doi.org/10.1007/s00894-022-05341-2

Ejemplares similares

Diphenyl Diselenide and SARS-CoV-2: in silico Exploration of the Mechanisms of Inhibition of Main Protease (M(pro)) and Papain-like Protease (PL(pro))
por: Omage, Folorunsho Bright, et al.
Publicado: (2023)

In silico studies of M(pro) and PL(pro) from SARS-CoV-2 and a new class of cephalosporin drugs containing 1,2,4-thiadiazole
por: Delgado, Cássia Pereira, et al.
Publicado: (2022)

The Se(…)S/N interactions as a possible mechanism of δ-aminolevulinic acid dehydratase enzyme inhibition by organoselenium compounds: A computational study
por: Nogara, Pablo Andrei, et al.
Publicado: (2020)

Application of Disulfiram and its Metabolites in Treatment of Inflammatory Disorders
por: Guo, Wenyi, et al.
Publicado: (2022)

Discovery of PL(pro) and M(pro) Inhibitors for SARS-CoV-2
por: Puhl, Ana C., et al.
Publicado: (2023)

Disulfiram Induced Psychosis
por: Mohapatra, Satyakam, et al.
Publicado: (2017)

Disulfiram Treatment of Alcoholism
por: Anton, Raymond F.
Publicado: (1995)

Encephalopathy caused by disulfiram
por: Sant’Angelo, R., et al.
Publicado: (2021)

Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents
por: Kannappan, Vinodh, et al.
Publicado: (2021)

Repurposing Disulfiram as an Antifungal Agent: Development of a New Disulfiram Vaginal Mucoadhesive Gel
por: Lajarin-Reinares, Maria, et al.
Publicado: (2023)

Effect of Methylmercury Binding on the Peroxide-Reducing Potential of Cysteine and Selenocysteine
por: Madabeni, Andrea, et al.
Publicado: (2021)

In the Chalcogenoxide Elimination Panorama: Systematic Insight into a Key Reaction
por: Madabeni, Andrea, et al.
Publicado: (2022)

Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
por: Lin, Min-Han, et al.
Publicado: (2018)

Plasma lipid metabolites as potential biomarkers for identifying individuals at risk of obesity-induced metabolic complications
por: Bellot, Paula Emília Nunes Ribeiro, et al.
Publicado: (2023)

Disulfiram—Mitigating Unintended Effects
por: Grout, Martha M., et al.
Publicado: (2023)

Disulfiram: Mechanisms, Applications, and Challenges
por: Lanz, Jenna, et al.
Publicado: (2023)

Spatial and temporal roles of SARS‐CoV PL(pro)—A snapshot
por: Yan, Shaomin, et al.
Publicado: (2020)

SARS-CoV-PL(pro)-Inhibitoren als mögliche Breitspektrum-Virostatika
por: Hammerschmidt, Stefan Josef, et al.
Publicado: (2021)

“Identification of Nafamostat and VR23 as COVID-19 drug candidates by targeting 3CL(pro) and PL(pro)"
por: Bhowmik, Deep, et al.
Publicado: (2021)

Cannabidiol‐induced activation of the metallothionein pathway impedes anticancer effects of disulfiram and its metabolite CuET
por: Buchtova, Tereza, et al.
Publicado: (2021)

ADVERSE EFFECTS OF DISULFIRAM AND PATIENT COMPLIANCE
por: Srinivasan, T.N., et al.
Publicado: (1996)

EVALUATION OF DISULFIRAM IN THE TREATMENT OF ALCOHOLISM1
por: Bagadia, V.N., et al.
Publicado: (1982)

Psychosis and enuresis during disulfiram therapy
por: Sherif, P.A., et al.
Publicado: (2006)

Disulfiram neuropathy: two case reports
por: Tran, Anh Thu, et al.
Publicado: (2016)

Cisplatin resistance reversal by disulfiram and caffeine
por: Kadia, Ashish R., et al.
Publicado: (2016)

Disulfiram: Reaction with ethanol: case report
Publicado: (2020)

Disulfiram-Induced Acute Liver Injury
por: Ramer, Lucas, et al.
Publicado: (2020)

Epileptic Seizure Due to Disulfiram Treatment
por: Erensoy, Habib, et al.
Publicado: (2019)

Antibacterial Effects of Disulfiram in Helicobacter pylori
por: Kobatake, Tomomi, et al.
Publicado: (2021)

In Silico and In Vitro Inhibition of SARS-CoV-2 PL(pro) with Gramicidin D
por: Protić, Sara, et al.
Publicado: (2023)

Pro-resolving and anti-arthritic properties of the MC(1) selective agonist PL8177
por: Garrido-Mesa, Jose, et al.
Publicado: (2022)

Diagnosis of feline pancreatitis with SNAP fPL and Spec fPL
por: Schnauß, Fanny, et al.
Publicado: (2018)

Selenium-Catalyzed Reduction of Hydroperoxides in Chemistry and Biology
por: Orian, Laura, et al.
Publicado: (2021)

Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PL(PRO) and 3CL(PRO) proteases
por: Jade, Dhananjay, et al.
Publicado: (2021)

In silico study of natural compounds from sesame against COVID-19 by targeting M(pro), PL(pro) and RdRp
por: Allam, Ahmed E., et al.
Publicado: (2021)

Development of 2-chloroquinoline based heterocyclic frameworks as dual inhibitors of SARS-CoV-2 M(Pro) and PL(Pro)
por: Kattula, Bhavita, et al.
Publicado: (2023)

Disulfiram Suppressed Peritendinous Fibrosis Through Inhibiting Macrophage Accumulation and Its Pro-inflammatory Properties in Tendon Bone Healing
por: Zhou, Qi, et al.
Publicado: (2022)

Oxidizing to death: Disulfiram for cancer cell killing
por: Brüning, Ansgar, et al.
Publicado: (2014)

A Case of Psychosis in Disulfiram Treatment for Alcoholism
por: de Melo, Raquel Calvão, et al.
Publicado: (2014)

New Disulfiram Derivatives as MAGL-Selective Inhibitors
por: Omran, Ziad
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6u00dk8qah6ae9a4974hiqr0ni